In Section 5.1, we will discuss the evidence that SCFAs are increased in response to the MedDiet and this excellent study by Sanna et al., combined with the other literature, allow us to associate the MedDiet to SCFA changes to an impaired insulin response and obesity
Adult mice may have serum antibodies but no clinical signs and few, if any, histopathologic lesions
The Evidence: Most research is limited to animal models, where taurine has been shown to stimulate GLP-1 secretion
Protein kinase A mediates glucagon-like peptide 1-induced nitric oxide production and muscle microvascular recruitment
The incidence of malformations exceeded concurrent and historical controls at 0.01 mg/kg/day (kidneys, scapula), greater than or equal to 0.01 mg/kg/day (eyes, forelimb), 0.025 mg/kg/day (brain, tail and sacral vertebrae, major blood vessels and heart, umbilicus), greater than or equal to 0.025 mg/kg/day (sternum) and at 0.05 mg/kg/day (parietal bones, major blood vessels)
The company made this prediction on the timing of FDA approval as it announced top-line results of a Phase 3 study showing a nearly 16% overall weight loss over a 17-month period among people who have both Type 2 diabetes and obesity 1